Yes, it's subjective. In healthcare we should als
Post# of 148164
(Total Views: 379)
Posted On: 04/17/2020 11:02:28 AM
Yes, it's subjective.
In healthcare we should also look at economics. Alas.
People will not get Leronlimab as a treatment in the end.
We lack money.
BP will beat us.
Thus our efforts are useless.
Better spend our money to the people we can really help.
In healthcare we should also look at economics. Alas.
People will not get Leronlimab as a treatment in the end.
We lack money.
BP will beat us.
Thus our efforts are useless.
Better spend our money to the people we can really help.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼